Effect of CYP3A-inducing anti-epileptics on sorafenib exposure: results of a phase II study of sorafenib plus daily temozolomide in adults with recurrent glioblastoma

Author: Reardon David   Vredenburgh James   Desjardins Annick   Peters Katherine   Gururangan Sridharan   Sampson John   Marcello Jennifer   Herndon James   McLendon Roger   Janney Dorothea   Friedman Allan   Bigner Darell   Friedman Henry  

Publisher: Springer Publishing Company

ISSN: 0167-594X

Source: Journal of Neuro-Oncology, Vol.101, Iss.1, 2011-01, pp. : 57-66

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content